Enovis saw the highest growth of 1.26% in patent filings and 1.72% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.26% and grants by 1.72%. GlobalData’s DataBook provides a comprehensive analysis of Enovis‘s patent filings and grants. Buy the databook here.
Enovis has been focused on protecting inventions in United States(US) with 36 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 44% filings and 43% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Enovis is filings its patents. Among the top granted patent authorities, Enovis has 43% of its grants in United States(US), 21% in European Patent Office(EPO) and 19% in Spain(ES).
Anika Therapeutics could be the strongest competitor for Enovis
In terms of grant share, Enovis stands first among its competitors followed by Enovis and Anika Therapeutics.
Patents related to industrial automation and healthtech lead Enovis's portfolio
Enovis has the highest number of patents in industrial automation followed by, healthtech and 3d printing. For industrial automation, nearly 16% of patents were filed and 12% of patents were granted in Q2 2024.
Orthopedic devices related patents lead Enovis portfolio followed by general surgery devices, and diagnostic imaging
Enovis has highest number of patents in orthopedic devices followed by general surgery devices, diagnostic imaging, encryption, and cad, cam & cae. For orthopedic devices, nearly 39% of patents were filed and 44% of patents were granted in Q2 2024.
For comprehensive analysis of Enovis's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.